Pages that link to "Q26783535"
Jump to navigation
Jump to search
The following pages link to The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones (Q26783535):
Displaying 47 items.
- Hunger and Satiety Mechanisms and Their Potential Exploitation in the Regulation of Food Intake (Q26772113) (← links)
- Microbial regulation of GLP-1 and L-cell biology (Q28072517) (← links)
- Gastrorenal Axis (Q30277035) (← links)
- Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake (Q33593471) (← links)
- Novel genes involved in severe early-onset obesity revealed by rare copy number and sequence variants (Q33724980) (← links)
- Treatment of Obesity: Weight Loss and Bariatric Surgery (Q36956145) (← links)
- GLP-2: A POORLY UNDERSTOOD MEDIATOR ENROLLED IN VARIOUS BARIATRIC/METABOLIC SURGERY-RELATED PATHOPHYSIOLOGIC MECHANISMS. (Q37579497) (← links)
- Roles of the gut in the metabolic syndrome: an overview (Q38780926) (← links)
- Recent advances in the modification of taste and food preferences following bariatric surgery. (Q38849378) (← links)
- Gastrointestinal-Renal Axis: Role in the Regulation of Blood Pressure (Q39164330) (← links)
- Red cell distribution width is a novel biomarker that predicts excess body-mass index loss 1 year after laparoscopic Roux-en-Y gastric bypass (Q41549790) (← links)
- The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans. (Q45988896) (← links)
- Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? (Q47144515) (← links)
- Mechanisms of weight loss and improved metabolism following bariatric surgery (Q47190446) (← links)
- An Optimized IES Method and Its Inhibitory Effects and Mechanisms on Food Intake and Body Weight in Diet-Induced Obese Rats: IES for Obesity (Q47210652) (← links)
- Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery (Q47992176) (← links)
- A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy (Q48035253) (← links)
- Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study (Q48238552) (← links)
- Bariatric Surgery Induces White and Grey Matter Density Recovery in the Morbidly Obese: A Voxel-Based Morphometric Study (Q48629197) (← links)
- Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes. (Q49597814) (← links)
- Omeprazole Absorption and Fasting Gastrinemia After Roux-en-Y Gastric Bypass. (Q51269534) (← links)
- Genetic determinants of circulating GIP and GLP-1 concentrations. (Q52837850) (← links)
- The Mechanism of Metabolic Surgery: Gastric Center Hypothesis: Letter to the Editor. (Q54447206) (← links)
- Are peptide conjugates the golden therapy against obesity? (Q55427238) (← links)
- Gut hormone release after gastric bypass depends on the length of the biliopancreatic limb (Q57118976) (← links)
- Bone Health After Bariatric Surgery (Q57145864) (← links)
- Technical Feasibility of a Murine Model of Sleeve Gastrectomy with Ileal Transposition (Q57799053) (← links)
- Common bile duct dilation after bariatric surgery (Q57800116) (← links)
- Exclusively endoscopic approach to treating gastric perforation caused by an intragastric balloon: case series and literature review (Q58550995) (← links)
- The Type of Bariatric Surgery Impacts the Risk of Acute Pancreatitis: A Nationwide Study (Q58748813) (← links)
- Small Bowel Endoscopic Bariatric Therapies (Q59127264) (← links)
- Effects of hemodialysis combined with hemoperfusion on severe acute pancreatitis. (Q64911140) (← links)
- Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a pro (Q64956935) (← links)
- Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations (Q87926522) (← links)
- Can Peptides and Gut Microbiota Be Involved in the Etiopathology of Obesity? (Q88638529) (← links)
- The effect of bariatric surgery on the retrobulbar flow hemodynamic parameters in patients with obesity: color Doppler evaluation (Q88647399) (← links)
- Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes (Q89113530) (← links)
- Nonalcoholic fatty liver disease (Q89216668) (← links)
- Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight loss (Q89599740) (← links)
- Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions (Q89940067) (← links)
- The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity (Q90533544) (← links)
- Metabolic and Endocrine Consequences of Bariatric Surgery (Q90680826) (← links)
- The role of dietary sugars in health: molecular composition or just calories? (Q91763378) (← links)
- Roux‑en‑Y gastric bypass surgery triggers rapid DNA fragmentation in vagal afferent neurons in rats (Q92306742) (← links)
- GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans (Q93365343) (← links)
- Exendin-4(Lys27 PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) mice (Q93384252) (← links)
- Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis (Q96026590) (← links)